← Back to Search

Behavioral Intervention

Mentoring Program for Transgender Youth (TCP Trial)

N/A
Recruiting
Led By Katie M Edwards, PhD
Research Sponsored by University of Nebraska Lincoln
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Youth must identify as transgender and/or gender minority youth (TGMY)
Youth must be between the ages of 14 to 18 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up time 1 (baseline, pre-intervention), time 2 (immediately post-intervention), time 3 (3 months post-intervention)
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to create an online mentoring and skill-building program called the Teen Connection Project for transgender and/or gender minority youth aged 14 to 18. The program consists of seven 90-minute sessions

Who is the study for?
This trial is for transgender and/or gender minority youth aged 14 to 18 who may be experiencing anxiety, depression, suicidal thoughts, or engaging in risky behaviors like drug use or alcohol consumption. Participants should not have any conditions that would exclude them from safely participating in an online mentoring program.
What is being tested?
The Teen Connection Project (TCP) is being tested. It's a series of seven online sessions lasting 90 minutes each where transgender and/or gender minority youth are paired with adult mentors for skill-building activities aimed at improving social-emotional skills.
What are the potential side effects?
Since TCP is a non-medical intervention focusing on mentorship and skill development, there are no direct medical side effects. However, discussing sensitive topics could potentially cause emotional discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I identify as transgender or part of a gender minority.
Select...
I am between 14 and 18 years old.
Select...
I can read and speak English.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~time 1 (baseline, pre-intervention), time 2 (immediately post-intervention), time 3 (3 months post-intervention)
This trial's timeline: 3 weeks for screening, Varies for treatment, and time 1 (baseline, pre-intervention), time 2 (immediately post-intervention), time 3 (3 months post-intervention) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Alcohol Use (Youth-reported)
Anxiety symptoms (Youth-reported)
DSV perpetration-1 (Youth-reported)
+7 more
Other study objectives
Gender Minority Stress (Youth-reported)
Hope for the Future (Youth-reported)
Mentor Process Scale (Adult-reported)
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: TreatmentExperimental Treatment1 Intervention
The Teen Connection Project (TCP) is theoretically grounded, and follows best practices for effective health behavior prevention. It includes seven 90-minute sessions with group and one-on-one mentoring components. The intervention is facilitated by transgender and/or gender minority adults (i.e., any identity other than cisgender).
Group II: Waitlist controlActive Control1 Intervention
Provide check-ins, provide resources, and offer program after intervention and measurement has been completed.
Group III: MentorsActive Control1 Intervention
Mentors complete a two-day training and post-training survey, facilitate programming, and complete post-session surveys. A subset of the mentors will complete exit interviews.

Find a Location

Who is running the clinical trial?

University of Nebraska LincolnLead Sponsor
37 Previous Clinical Trials
12,836 Total Patients Enrolled
University of Rhode IslandOTHER
56 Previous Clinical Trials
22,317 Total Patients Enrolled
Katie M Edwards, PhDPrincipal InvestigatorUniversity of Nebraska Lincoln
2 Previous Clinical Trials
674 Total Patients Enrolled
~20 spots leftby Mar 2025